Madrigal Pharmaceuticals Files 8-K on Financials
Ticker: MDGL · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1157601
Sentiment: neutral
Topics: financial-reporting, operations, exhibits
Related Tickers: MDGL
TL;DR
Madrigal Pharma dropped an 8-K on Feb 26th covering financials. Check it out.
AI Summary
Madrigal Pharmaceuticals, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in West Conshohocken, Pennsylvania.
Why It Matters
This filing provides investors with crucial updates on Madrigal Pharmaceuticals' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or unusual risks.
Key Numbers
- 001-33277 — SEC File Number (Identifies the company's filing history with the SEC.)
- 04-3508648 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- MADRIGAL PHARMACEUTICALS, INC. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- West Conshohocken, Pennsylvania (location) — Address of principal executive offices
- SYNTA PHARMACEUTICALS CORP (company) — Former company name
FAQ
What specific financial information is detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are not provided in the header.
When was Madrigal Pharmaceuticals, Inc. incorporated?
Madrigal Pharmaceuticals, Inc. was incorporated in Delaware.
What is the primary business address of Madrigal Pharmaceuticals?
The principal executive offices are located at Four Tower Bridge, 200 Barr Harbor Drive, Suite 200, West Conshohocken, Pennsylvania, 19428.
Has Madrigal Pharmaceuticals undergone a name change previously?
Yes, the company was formerly known as SYNTA PHARMACEUTICALS CORP, with a date of name change on August 15, 2001.
What is the telephone number provided for Madrigal Pharmaceuticals?
The registrant's telephone number, including area code, is (267) 824-2827.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding MADRIGAL PHARMACEUTICALS, INC. (MDGL).